Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

10-K/A - Apimeds Pharmaceuticals US, Inc | StockGist | StockGist

Companies
APUS
10-K/A

Home Top Movers Companies Concepts

Home Filings APUS10-K/A

10-K/A

Periodic Report

Amendment

Apimeds Pharmaceuticals US, Inc

Filed May 2, 2025

Accepted May 1, 2025, 8:00 PM ET

CIK 0001894525

View on SEC.gov Company Profile

Amendment History

2 filings

10-K
Original
Apr 15, 20250001213900-25-032206
10-K/A
Amendment 1
Latest
Viewing
May 2, 20250001213900-25-038644

Key Facts

Fiscal Year

2024

Period

FY

Period End

Dec 31, 2024

Recent Filings

Apimeds Pharmaceuticals US, Inc1 weeks ago

Apimeds Pharmaceuticals US, Inc1 weeks ago

Apimeds Pharmaceuticals US, Inc1 months ago

Apimeds Pharmaceuticals US, Inc1 months ago

Apimeds Pharmaceuticals US, Inc2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice